Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Luk

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Eye (London, England)|April 9, 2015
Focal choroidal excavation in patients with central serous chorioretinopathyF O J Luk, A C T Fok, A Lee, et al.
Rheumatology (Oxford, England)|May 19, 2009
Allopurinol and mortality in hyperuricaemic patientsAndrew J Luk, Gregory P Levin, Elya E Moore, et al.
The British Journal of Ophthalmology|March 22, 2008
Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathyT Y Y Lai, W-M Chan, D T L Liu, et al.
The EMBO Journal|December 6, 2003
Mouse Rev1 protein interacts with multiple DNA polymerases involved in translesion DNA synthesisCaixia Guo, Paula L Fischhaber, Margaret J Luk-Paszyc, et al.
American Journal of Ophthalmology|June 15, 2005
Solitary superficial angiomyxoma in the eyelidHunter K L Yuen, W Cheuk, Fiona O J Luk, et al.
Retina (Philadelphia, Pa.)|November 26, 2009
Visual outcomes and growth factor changes of two dosages of intravitreal bevacizumab for neovascular age-related macular degeneration: a randomized, controlled trialTimothy Y Y Lai, David T L Liu, Kwok-Ping Chan, et al.
IEEE Transactions on Visualization and Computer Graphics|October 28, 2020
Visual cohort comparison for spatial single-cell omics-dataAntonios Somarakis, Marieke E Ijsselsteijn, Sietse J Luk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2023
Balanced Epigenetic Regulation of MHC Class I Expression in Tumor Cells by the Histone Ubiquitin Modifiers BAP1 and PCGF1Ruud H Wijdeven, Sietse J Luk, Tom A W Schoufour, et al.
Clinical & Experimental Ophthalmology|August 28, 2010
Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy eraTimothy Y Y Lai, Raymond L M Wong, Fiona O J Luk, et al.
Investigative Ophthalmology & Visual Science|December 27, 2023
PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal MelanomaMaria Chiara Gelmi, Gulçin Gezgin, Pieter A van der Velden, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Eye (London, England)|April 9, 2015
Focal choroidal excavation in patients with central serous chorioretinopathyF O J Luk, A C T Fok, A Lee, et al.
Rheumatology (Oxford, England)|May 19, 2009
Allopurinol and mortality in hyperuricaemic patientsAndrew J Luk, Gregory P Levin, Elya E Moore, et al.
The British Journal of Ophthalmology|March 22, 2008
Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathyT Y Y Lai, W-M Chan, D T L Liu, et al.
The EMBO Journal|December 6, 2003
Mouse Rev1 protein interacts with multiple DNA polymerases involved in translesion DNA synthesisCaixia Guo, Paula L Fischhaber, Margaret J Luk-Paszyc, et al.
American Journal of Ophthalmology|June 15, 2005
Solitary superficial angiomyxoma in the eyelidHunter K L Yuen, W Cheuk, Fiona O J Luk, et al.
Retina (Philadelphia, Pa.)|November 26, 2009
Visual outcomes and growth factor changes of two dosages of intravitreal bevacizumab for neovascular age-related macular degeneration: a randomized, controlled trialTimothy Y Y Lai, David T L Liu, Kwok-Ping Chan, et al.
IEEE Transactions on Visualization and Computer Graphics|October 28, 2020
Visual cohort comparison for spatial single-cell omics-dataAntonios Somarakis, Marieke E Ijsselsteijn, Sietse J Luk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2023
Balanced Epigenetic Regulation of MHC Class I Expression in Tumor Cells by the Histone Ubiquitin Modifiers BAP1 and PCGF1Ruud H Wijdeven, Sietse J Luk, Tom A W Schoufour, et al.
Clinical & Experimental Ophthalmology|August 28, 2010
Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy eraTimothy Y Y Lai, Raymond L M Wong, Fiona O J Luk, et al.
Investigative Ophthalmology & Visual Science|December 27, 2023
PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal MelanomaMaria Chiara Gelmi, Gulçin Gezgin, Pieter A van der Velden, et al.
Pageof 5